Cargando…
Signalling pathways implicated in the pathogenesis of rheumatic heart disease (Review)
Rheumatic heart disease (RHD) is frequently encountered in underdeveloped areas and primarily affects patients under the age of 40 years old. The pathogenesis of RHD has yet to be fully elucidated and surgical treatment remains the only option, which is expensive and technically demanding for patien...
Autores principales: | Xian, Shenglin, Zeng, Zhiyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716644/ https://www.ncbi.nlm.nih.gov/pubmed/33365076 http://dx.doi.org/10.3892/etm.2020.9508 |
Ejemplares similares
-
Activation of activin/Smad2 and 3 signaling pathway and the potential involvement of endothelial-mesenchymal transition in the valvular damage due to rheumatic heart disease
por: Xian, Shenglin, et al.
Publicado: (2021) -
Interference with the expression of S1PR1 or STAT3 attenuates valvular damage due to rheumatic heart disease
por: Xian, Shenglin, et al.
Publicado: (2021) -
Inhibition of miR-155-5p attenuates the valvular damage induced by rheumatic heart disease
por: Chen, Ang, et al.
Publicado: (2020) -
Neutrophils in the Pathogenesis of Rheumatic Diseases
por: Loh, Jia Tong, et al.
Publicado: (2022) -
Genes, autoimmunity and pathogenesis of rheumatic heart disease
por: Guilherme, L, et al.
Publicado: (2011)